• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

红细胞凋亡作为帕金森病的一个标志物。

Eryptosis as a marker of Parkinson's disease.

作者信息

Pretorius Etheresia, Swanepoel Albe C, Buys Antoinette V, Vermeulen Natasha, Duim Wiebren, Kell Douglas B

机构信息

Department of Physiology, Faculty of Health Sciences, University of Pretoria, Arcadia 0007, South Africa.

Microscopy and Microanalysis Unit, University of Pretoria, Arcadia 0007, South Africa.

出版信息

Aging (Albany NY). 2014 Oct;6(10):788-819. doi: 10.18632/aging.100695.

DOI:10.18632/aging.100695
PMID:25411230
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4247384/
Abstract

A major trend in recent Parkinson's disease (PD) research is the investigation of biological markers that could help in identifying at-risk individuals or to track disease progression and response to therapies. Central to this is the knowledge that inflammation is a known hallmark of PD and of many other degenerative diseases. In the current work, we focus on inflammatory signalling in PD, using a systems approach that allows us to look at the disease in a more holistic way. We discuss cyclooxygenases, prostaglandins, thromboxanes and also iron in PD. These particular signalling molecules are involved in PD pathophysiology, but are also very important in an aberrant coagulation/hematology system. We present and discuss a hypothesis regarding the possible interaction of these aberrant signalling molecules implicated in PD, and suggest that these molecules may affect the erythrocytes of PD patients. This would be observable as changes in the morphology of the RBCs and of PD patients relative to healthy controls. We then show that the RBCs of PD patients are indeed rather dramatically deranged in their morphology, exhibiting eryptosis (a kind of programmed cell death). This morphological indicator may have useful diagnostic and prognostic significance.

摘要

帕金森病(PD)研究的一个主要趋势是对生物标志物进行研究,这些生物标志物有助于识别高危个体,或追踪疾病进展以及对治疗的反应。其中的核心是,炎症是PD以及许多其他退行性疾病的一个已知特征。在当前的研究中,我们聚焦于PD中的炎症信号传导,采用一种系统方法,使我们能够以更全面的方式看待这种疾病。我们讨论了环氧化酶、前列腺素、血栓素以及PD中的铁。这些特定的信号分子参与了PD的病理生理学过程,但在异常的凝血/血液系统中也非常重要。我们提出并讨论了一个关于这些与PD相关的异常信号分子可能相互作用的假说,并表明这些分子可能会影响PD患者的红细胞。相对于健康对照,这将表现为PD患者红细胞形态的变化。然后我们表明,PD患者的红细胞形态确实出现了相当显著的紊乱,表现为红细胞凋亡(一种程序性细胞死亡)。这种形态学指标可能具有有用的诊断和预后意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/e68b4344fe9f/aging-06-788-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/d561500c7f85/aging-06-788-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/634d0e2f3e12/aging-06-788-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/d66cafb4e490/aging-06-788-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/a11411d02987/aging-06-788-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/6384e0060e1a/aging-06-788-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/a30c03d9a26d/aging-06-788-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/15ab51ea11e9/aging-06-788-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/ecb4e4492814/aging-06-788-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/238b5d220ecb/aging-06-788-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/63ac270a533c/aging-06-788-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/a30a2de17591/aging-06-788-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/6d1f73509325/aging-06-788-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/e68b4344fe9f/aging-06-788-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/d561500c7f85/aging-06-788-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/634d0e2f3e12/aging-06-788-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/d66cafb4e490/aging-06-788-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/a11411d02987/aging-06-788-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/6384e0060e1a/aging-06-788-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/a30c03d9a26d/aging-06-788-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/15ab51ea11e9/aging-06-788-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/ecb4e4492814/aging-06-788-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/238b5d220ecb/aging-06-788-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/63ac270a533c/aging-06-788-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/a30a2de17591/aging-06-788-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/6d1f73509325/aging-06-788-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46d/4247384/e68b4344fe9f/aging-06-788-g013.jpg

相似文献

1
Eryptosis as a marker of Parkinson's disease.红细胞凋亡作为帕金森病的一个标志物。
Aging (Albany NY). 2014 Oct;6(10):788-819. doi: 10.18632/aging.100695.
2
Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.帕金森病中的铁与氧化应激:损伤生物标志物的观察性研究
PLoS One. 2016 Jan 11;11(1):e0146129. doi: 10.1371/journal.pone.0146129. eCollection 2016.
3
Red cell distribution width levels in Parkinson's disease patients.帕金森病患者的红细胞分布宽度水平。
Acta Neurol Belg. 2020 Oct;120(5):1147-1150. doi: 10.1007/s13760-019-01197-1. Epub 2019 Jul 31.
4
Lower hemoglobin levels in patients with parkinson's disease are associated with disease severity and iron metabolism.帕金森病患者较低的血红蛋白水平与疾病严重程度和铁代谢有关。
Brain Res. 2017 Jan 15;1655:145-151. doi: 10.1016/j.brainres.2016.11.007. Epub 2016 Nov 10.
5
Total and Proteinase K-Resistant α-Synuclein Levels in Erythrocytes, Determined by their Ability to Bind Phospholipids, Associate with Parkinson's Disease.通过红细胞结合磷脂的能力测定的总α-突触核蛋白水平和抗蛋白酶K的α-突触核蛋白水平与帕金森病相关。
Sci Rep. 2015 Jun 11;5:11120. doi: 10.1038/srep11120.
6
Striatal blood-brain barrier permeability in Parkinson's disease.帕金森病中纹状体血脑屏障的通透性
J Cereb Blood Flow Metab. 2015 May;35(5):747-50. doi: 10.1038/jcbfm.2015.32. Epub 2015 Mar 11.
7
The serum ferrokinetics in Parkinson's disease.帕金森病中的血清铁动力学
Gaoxiong Yi Xue Ke Xue Za Zhi. 1992 Nov;8(11):581-4.
8
Decreased serum ferritin may be associated with increased restless legs syndrome in Parkinson's disease (PD): a meta-analysis for the diagnosis of RLS in PD patients.血清铁蛋白降低可能与帕金森病(PD)中不宁腿综合征(RLS)的增加有关:PD 患者 RLS 诊断的荟萃分析。
Int J Neurosci. 2019 Oct;129(10):995-1003. doi: 10.1080/00207454.2019.1608200. Epub 2019 Jun 17.
9
Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents.血色病或高血铁蛋白症患者的红细胞和纤维蛋白网络的深刻形态变化,以及铁螯合剂和其他药物的正常化。
PLoS One. 2014 Jan 9;9(1):e85271. doi: 10.1371/journal.pone.0085271. eCollection 2014.
10
Red Blood Cells' Thermodynamic Behavior in Neurodegenerative Pathologies and Aging.红细胞在神经退行性病变和衰老中的热力学行为。
Biomolecules. 2021 Oct 12;11(10):1500. doi: 10.3390/biom11101500.

引用本文的文献

1
Current understanding of eryptosis: mechanisms, physiological functions, role in disease, pharmacological applications, and nomenclature recommendations.红细胞凋亡的当前认识:机制、生理功能、在疾病中的作用、药理学应用及命名建议
Cell Death Dis. 2025 Jul 1;16(1):467. doi: 10.1038/s41419-025-07784-w.
2
Cell death signaling in human erythron: erythrocytes lose the complexity of cell death machinery upon maturation.人类红细胞生成过程中的细胞死亡信号传导:红细胞成熟后失去了细胞死亡机制的复杂性。
Apoptosis. 2025 Apr;30(3-4):652-673. doi: 10.1007/s10495-025-02081-5. Epub 2025 Feb 9.
3
Deformability of Heterogeneous Red Blood Cells in Aging and Related Pathologies.

本文引用的文献

1
The molecular mechanism of intestinal levodopa absorption and its possible implications for the treatment of Parkinson's disease.肠道左旋多巴吸收的分子机制及其对帕金森病治疗的潜在意义。
J Pharmacol Exp Ther. 2014 Oct;351(1):114-23. doi: 10.1124/jpet.114.216317. Epub 2014 Jul 29.
2
A new HILIC-MS/MS method for the simultaneous analysis of carbidopa, levodopa, and its metabolites in human plasma.一种用于同时分析人血浆中卡比多巴、左旋多巴及其代谢物的新型亲水作用色谱-串联质谱法。
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Sep 15;967:41-9. doi: 10.1016/j.jchromb.2014.06.030. Epub 2014 Jul 14.
3
The benefits of pramipexole selection in the treatment of Parkinson's disease.
衰老及相关病理状态下异质性红细胞的变形性
Aging Dis. 2024 Jun 19;16(3):1242-1264. doi: 10.14336/AD.2024.0526.
4
Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson's Disease.外周 MC1R 激活调节免疫反应并在帕金森病小鼠模型中具有神经保护作用。
J Neuroimmune Pharmacol. 2023 Dec;18(4):704-717. doi: 10.1007/s11481-023-10094-7. Epub 2023 Dec 19.
5
Morphometric and Nanomechanical Screening of Peripheral Blood Cells with Atomic Force Microscopy for Label-Free Assessment of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.采用原子力显微镜对外周血细胞进行形态计量学和纳米力学筛选,用于阿尔茨海默病、帕金森病和肌萎缩性侧索硬化症的无标记评估。
Int J Mol Sci. 2023 Sep 19;24(18):14296. doi: 10.3390/ijms241814296.
6
Calcium influx: An essential process by which α-Synuclein regulates morphology of erythrocytes.钙离子内流:α-突触核蛋白调节红细胞形态的必要过程。
J Adv Res. 2024 Aug;62:187-198. doi: 10.1016/j.jare.2023.09.009. Epub 2023 Sep 13.
7
Literature-Based Discovery Predicts Antihistamines Are a Promising Repurposed Adjuvant Therapy for Parkinson's Disease.基于文献的发现表明抗组胺药是一种有前途的帕金森病辅助治疗药物。
Int J Mol Sci. 2023 Aug 2;24(15):12339. doi: 10.3390/ijms241512339.
8
Erythrocytes Functionality in SARS-CoV-2 Infection: Potential Link with Alzheimer's Disease.红细胞在 SARS-CoV-2 感染中的功能:与阿尔茨海默病的潜在关联。
Int J Mol Sci. 2023 Mar 17;24(6):5739. doi: 10.3390/ijms24065739.
9
Molecular Mechanisms and Pathophysiological Significance of Eryptosis.促红细胞生成性细胞凋亡的分子机制及病理生理学意义。
Int J Mol Sci. 2023 Mar 7;24(6):5079. doi: 10.3390/ijms24065079.
10
Casein kinase 1α mediates eryptosis: a review.酪蛋白激酶1α介导红细胞凋亡:综述
Apoptosis. 2023 Feb;28(1-2):1-19. doi: 10.1007/s10495-022-01776-3. Epub 2022 Oct 29.
普拉克索在帕金森病治疗中的选择优势。
Neurol Sci. 2014 Oct;35(10):1505-11. doi: 10.1007/s10072-014-1891-5. Epub 2014 Jul 20.
4
Molecular interactions between amantadine and model cell membranes.金刚烷胺与模型细胞膜之间的分子相互作用。
Langmuir. 2014 Jul 22;30(28):8491-9. doi: 10.1021/la501718n. Epub 2014 Jul 10.
5
Safety overview of FDA-approved medications for the treatment of the motor symptoms of Parkinson's disease.FDA 批准的治疗帕金森病运动症状药物的安全性概述。
Expert Opin Drug Saf. 2014 Aug;13(8):1055-69. doi: 10.1517/14740338.2014.931369. Epub 2014 Jun 24.
6
'Neuroinflammation' differs categorically from inflammation: transcriptomes of Alzheimer's disease, Parkinson's disease, schizophrenia and inflammatory diseases compared.“神经炎症”与炎症截然不同:比较阿尔茨海默病、帕金森病、精神分裂症和炎症性疾病的转录组
Neurogenetics. 2014 Aug;15(3):201-12. doi: 10.1007/s10048-014-0409-x. Epub 2014 Jun 15.
7
Iron, oxidative stress, and redox signaling in the cardiovascular system.心血管系统中的铁、氧化应激与氧化还原信号传导
Mol Nutr Food Res. 2014 Aug;58(8):1721-38. doi: 10.1002/mnfr.201400036. Epub 2014 May 30.
8
Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease.普拉克索缓释剂在早期及晚期帕金森病中的长期安全性和持续疗效
Eur J Neurol. 2014 May;21(5):736-43. doi: 10.1111/ene.12375.
9
Entacapone reduces cortical activation in Parkinson's disease with wearing-off: a f-MRI study.恩他卡朋可减轻帕金森病剂末现象时的皮质激活:一项功能磁共振成像研究。
PLoS One. 2014 May 15;9(5):e96806. doi: 10.1371/journal.pone.0096806. eCollection 2014.
10
mitoNEET as a novel drug target for mitochondrial dysfunction.米托萘醌作为线粒体功能障碍的新型药物靶点。
Drug Discov Today. 2014 Oct;19(10):1601-6. doi: 10.1016/j.drudis.2014.05.001. Epub 2014 May 9.